Eurazeo: Undervalued European Private Markets Powerhouse with Asymmetric Upside
Eurazeo SE is a leading Paris-based investment group specializing in private markets. The company operates across three main asset classes – Private Equity, Private Debt, and Real Assets – with a focus on mid-market and growth-oriented companies across sectors like technology, healthcare, consumer brands, and infrastructure. As of mid-2025, Eurazeo manages roughly €36–37 billion in diversified assets (about €27 billion for institutional and private clients, and €9–10 billion of its own “permanent” capital) across 600+ portfolio companies worldwide. These investments span buyouts, growth equity, venture capital, private credit for SMEs, and real assets such as real estate and renewable infrastructure projects, making Eurazeo a broadly diversified private markets asset manager.
Eurazeo’s business model blends third-party asset management with direct balance-sheet investing. This means it earns recurring management fees (typically 1–2% of AUM) on capital managed for clients, as well as performance fees and investment income from its own balance-sheet stakes in companies. The firm has a strong presence in Europe and growing international reach (offices in 13 cities globally), positioning itself as a major player in European mid-market private equity and private credit. Overall, Eurazeo’s key segments and strategies give it exposure to some of the most dynamic areas of the economy (tech, healthcare, energy transition, etc.), while its mix of fee income and investment returns aims to generate value for both its fund investors and its shareholders.
Revenue Drivers: Eurazeo’s income is driven by a combination of steady fee revenue and investment realization gains. On the steady side, management fees on third-party AUM have been growing consistently – rising ~7% in 2024 to €421 million – thanks to robust fundraising and new fund launches. Fee-Related Earnings (FRE), which measure the profit from the asset management business, grew +11% in 2024 to €150 million (with a healthy 35.5% margin). These stable fees (backed by long-term commitments from institutional investors and an increasing base of private wealth clients) provide a recurring revenue foundation. On the more variable side, Eurazeo realizes investment profits when it exits portfolio companies. 2024 saw a sharp uptick in exits, with €3.4 billion in realizations (triple the prior year’s volume) as Eurazeo took advantage of opportunities to sell or IPO certain holdings. These exits can generate significant one-time gains and performance fees, though they depend on market conditions. For example, in May 2025 Eurazeo completed the sale of its 70% stake in Albingia (a French insurer) for a 2.2x cash-on-cash return, bringing in roughly €289 million to the balance sheet – a testament to the value created in that investment. Overall, management fees and capital gains form the twin engines of Eurazeo’s business model, with the firm increasingly emphasizing the stable fee income as it grows its asset management platform.
Growth Initiatives: Eurazeo is pursuing an ambitious strategic roadmap for 2024–2027 centered on scaling up its asset management franchise and accelerating capital rotation. In 2024 (the first year of the plan), the company raised €4.3 billion of fresh capital (+23% vs 2023) across new and existing funds, including nearly €1.0 billion from retail and high-net-worth channels. Notably, private debt has been a growth engine, contributing €2.5 billion of inflows in 2024 as investors seek yield in private credit. Eurazeo is also expanding geographically – extending its fundraising reach in North America and Asia – and rolling out new products (such as wealth-management offerings in Germany, Benelux, and Italy) to tap a broader investor base. On the investment side, Eurazeo has been doubling its pace of balance-sheet rotation, realizing ~17% of its portfolio in 2024 (versus ~8% historically). This faster churn is deliberate: the firm is actively recycling capital from mature investments into new opportunities. Co-CEOs Christophe Bavière and William Kadouch-Chassaing have emphasized that Eurazeo “rigorously [rolls] out its strategic roadmap” even amid uncertain markets – meaning they are pushing ahead with exits (where they see good prices) and fundraising (leveraging Eurazeo’s track record) to drive growth. In H1 2025, for instance, Eurazeo achieved a first closing of its new Growth Fund IV at €650 million and a final closing of its flagship buyout Fund V at €3 billion, underlining the continued expansion of its fund platform.
Competitive Advantages: Eurazeo’s competitive moat lies in its diversified and scaled platform. Unlike many niche private equity houses, Eurazeo offers multi-asset-class expertise under one roof – from venture capital and mid-market buyouts to private debt and infrastructure – allowing it to serve investors across a spectrum of private market strategies and to cross-sell offerings. This diversification of both investment focus and revenue streams (fees + investment income) helps smooth out cyclicality: when exit activity is slow, management fees still provide income, and vice versa. Eurazeo also benefits from a stable base of long-term shareholders and investors, including institutional LPs and family offices that have backed the firm for years. This gives the firm patient capital and a network for sourcing deals. Furthermore, Eurazeo’s on-the-ground presence in 13 global offices and team of 400+ professionals provide deep local reach and sector specialization. The firm supports ~600 companies with this global network, which is a significant competitive edge in sourcing attractive mid-market deals and adding value to portfolio companies. Lastly, Eurazeo’s track record (management notes an average ~12% annual return across its funds historically) underpins its brand equity. Having a demonstrated history of value creation – exemplified by past successes like the lucrative exits of Moncler, Farfetch, or more recently Reden Solar (42% IRR on that 2017–2022 investment) – reinforces Eurazeo’s credibility with investors and entrepreneurs. In summary, a combination of scale, diversification, expertise, and proven results constitutes Eurazeo’s strategic advantages in an increasingly competitive private markets arena.
Recent Financial Performance (2024–2025): Eurazeo’s results over the past two years reflect strong operational progress, tempered by accounting impacts from market conditions. 2024 was marked by robust activity: management fees grew +7%, FRE (operating profit from fees) rose +11%, and portfolio companies delivered impressive growth (e.g. EBITDA of buyout holdings up +27%). The firm dramatically increased asset rotation, with €3.4 billion in exits in 2024 (vs just €1.3bn in 2023) and deployments of €4.6bn into new investments. This heightened activity created solid value creation at the portfolio level (+9% uplift on most assets), but it was offset by sizeable write-downs on a few legacy investments – notably a €0.4bn impairment in the mature buyout portfolio and €0.3bn in the growth portfolio. Those non-cash fair value adjustments dragged the bottom line into the red. Eurazeo reported a net loss (Group share) of ~€0.4 billion for 2024, largely due to these write-downs, despite the healthy operational performance. (By contrast, 2023 had shown a large reported net profit of €1.85 billion, but that was entirely driven by a one-off accounting gain from consolidation adjustments – excluding that, underlying 2023 was around breakeven). Moving into 2025, Eurazeo’s H1 2025 update showed continued momentum in asset management: AUM reached €36.8bn (+4% YoY) with third-party AUM up +10%, and management fees for the half-year were €211m (up modestly, +6% on a comparable basis). The balance sheet investment portfolio was valued at €7.4bn (≈ €103.4 per share) as of June 30, 2025, a slight decline from €107.8 per share at 2024’s end due to currency headwinds and the aforementioned write-downs. Realizations continued at a good clip in H1 (roughly 12% of the portfolio sold, including exits like Albingia and stakes in the CPK Group), yet net income remained negative (-€0.3bn in H1 2025) as further fair-value adjustments and forex effects flowed through. Importantly, Eurazeo’s fee-related earnings and cash generation remain positive (operating profit from asset management up +9% in H1), and the firm increased shareholder cash returns with a 10% higher dividend (€2.65 per share paid in May 2025) and an expanded €400m buyback program for 2025. In summary, Eurazeo’s underlying business is growing steadily and generating cash, even as accounting net profits have fluctuated due to market-driven valuation swings on its investments.
Current Valuation Multiples: Eurazeo’s stock price has materially lagged its intrinsic value indicators, reflecting cautious market sentiment. At around €51–52 per share in early August 2025, the stock trades at roughly 0.5x Price-to-NAV, given the latest reported NAV of ~€103 per share. In other words, the public market is valuing Eurazeo at just about half of the fair value of its underlying assets – a steep discount even by private equity sector standards. In traditional valuation terms, the stock also looks inexpensive: at €52, Eurazeo’s market capitalization (€3.8 billion) is only about 0.62× book value and around 10× forward earnings (based on normalized earnings power), whereas peers in asset management often trade closer to book value (1.0×) and 12–14× earnings. This 20–30% relative discount suggests investors are applying a hefty risk-premium for Eurazeo’s exposure to private markets. Indeed, concerns over near-term exit activity and portfolio marks have kept the stock subdued. However, many analysts see this as an overdone discount. As of July 2025, the consensus 12-month price target was around €85–95 per share, implying significant upside. Multiple investment banks have “Buy/Outperform” ratings on Eurazeo, citing its diversified fee income and asset value as compelling – for example, Goldman Sachs (Buy, €81 target) and Berenberg (Buy, €95 target) are optimistic about a re-rating. In short, Eurazeo’s current valuation multiples signal skepticism (likely about the pace of monetizations and macro risks), but if the company can deliver consistent results and narrow the gap between market price and NAV, there is substantial value to be unlocked for shareholders.
Eurazeo faces a number of risks, both company-specific and macro-driven, which investors should consider:
Fundraising Cyclicality: The flow of capital into private equity funds can be cyclical. In a downturn or risk-averse climate, institutional LPs and wealth clients might slow their commitments to private funds. Rising interest rates and better yields in public markets or bonds could also make it harder for Eurazeo to raise new funds. A significant pullback in fundraising would cap AUM growth and pressure management fee revenues.
Exit Environment & Valuations: Eurazeo’s ability to realize gains depends on a healthy exit market (M&A, IPOs). If the economy weakens or credit conditions tighten, buyers for private companies may dry up, prolonging holding periods. Prolonged weakness in the IPO or M&A markets would delay Eurazeo’s exits, thereby postponing performance fees and potentially forcing the firm to mark down portfolio valuations (as seen in 2024). A lack of exits not only hurts earnings but can also signal that carrying values might be too high, leading to further fair-value write-downs.
Portfolio Performance & Leverage: While Eurazeo’s portfolio is diversified, it is not immune to macroeconomic downturns. A recession or sector-specific shock (e.g. in consumer spending or tech) could impair the earnings and cash flows of its portfolio companies, reducing their valuations. Eurazeo also carries moderate leverage on its balance sheet (net debt ~€1.5 billion against €7.4 billion in assets)investing.com. Although this ~20% debt-to-asset ratio is not extreme, interest coverage is currently negative due to accounting losses. If cash flows from exits and fees were to deteriorate, high leverage could constrain Eurazeo’s financial flexibility for new investments or force asset sales at suboptimal times. The firm must manage liquidity carefully, especially with a commitment to shareholder payouts.
Regulatory and Structural Risks: Changes in regulations (for example, EU directives like AIFMD governing private fund managers) could increase compliance costs or restrict certain fee practices. Additionally, any adverse change in tax policy for private equity or in regulations for insurers/pension funds investing in private assets could dampen the appeal of the asset class. Eurazeo’s global operations also expose it to geopolitical and currency risks – as seen in H1 2025 when currency fluctuations shaved ~2% off portfolio value. Broader geopolitical tensions or trade issues could indirectly affect its deal-making and exits (for instance, if cross-border M&A is curtailed).
Market Sentiment & Valuation Risk: Because Eurazeo’s stock trades at a significant discount to NAV, market sentiment is a risk factor in itself. In periods of market stress, investment holding companies and asset managers can trade at even wider discounts, regardless of fundamental value. If investors broadly flee risk assets, Eurazeo’s share price could fall further (even if the intrinsic value of its portfolio is stable), increasing the cost of capital and potentially making it harder to use equity for growth or acquisitions.
In summary, Eurazeo’s fortunes are tied to the private market cycle – strong economic growth and buoyant capital markets create a tailwind (facilitating fundraising and exits), whereas a downturn or credit crunch is a dual headwind of slower fundraising and difficult exits. The company mitigates some of this with its fee-based income and diversification, but investors should be prepared for inherent volatility. Macro trends like interest rate movements, GDP growth, and financial market liquidity will significantly influence Eurazeo’s performance in the coming years.
To estimate Eurazeo’s 5-year potential, we consider three scenarios – High, Base, and Low – based on different assumptions about the company’s fundamentals and the private markets environment. In each scenario, we project a 5-year forward share price (around 2030) and a likely trajectory of how the stock might get there, then assign a subjective probability to each outcome. (All values in EUR; starting point for 2025 is approx €52 per share.)
High Case (optimistic fundamentals): Key drivers: In this scenario, Eurazeo capitalizes on a strong private markets rebound. AUM growth accelerates to high-single or low-double digits annually – driven by continued fundraising success (perhaps €3–4bn+ inflows per year) and possibly strategic acquisitions of smaller asset managers. By 2030, AUM could approach ~€60–70bn. Higher AUM plus a shift to more third-party capital lifts fee revenues significantly (management fees perhaps ~€600–800m by 2030). Meanwhile, the exit environment is very favorable: Eurazeo manages to sell several major holdings at attractive valuations (consistent with or above carrying value), realizing steady gains. Portfolio company performance remains robust, and earlier write-downs reverse into write-ups. NAV per share therefore rises moderately (from ~€103 in 2025 to perhaps ~€120 by 2030, after paying dividends), aided by some share buybacks (the company continues to repurchase undervalued shares, boosting per-share NAV). In the stock market, improved fundamentals and sentiment lead to a narrowing of the discount to NAV – investors start valuing Eurazeo closer to its asset value and strong fee earnings. We assume the stock might trade around 0.9–1.0x NAV in five years (versus ~0.5x today) given the higher confidence and more predictable cash flows (this still implies a modest conglomerate discount). Outcome: With NAV ~€120 and P/NAV ~0.95x, the share price in 5 years could reach roughly €114 (midpoint assumption). Including ~5% annual dividends, the total shareholder return would be very robust. Below is a possible share price trajectory under the High case: <table> <tr><th>Year</th><th>High-Case Share Price (€)</th></tr> <tr><td>2025 (current)</td><td>52</td></tr> <tr><td>2026</td><td>65</td></tr> <tr><td>2027</td><td>80</td></tr> <tr><td>2028</td><td>95</td></tr> <tr><td>2029</td><td>105</td></tr> <tr><td>2030</td><td>~114</td></tr> </table>
This path assumes the stock steadily re-rates upward as fundamentals beat expectations. Probability: We assign roughly 25% probability to this High scenario. Despite many favorable elements having to align, it reflects a plausible outcome if economic conditions are strong.
Base Case (moderate fundamentals): Key drivers: The base case envisions Eurazeo executing its strategy in a steady, unspectacular macro environment. AUM grows at a mid-single-digit pace (~5–7% CAGR), reaching around €45–50bn in 5 years – supported by ongoing (but not record-breaking) fundraising across strategies and maybe one or two new fund launches hitting targets. Fee revenue increases correspondingly (perhaps to ~€550m by 2030), and operating margins stay in the mid-30s%, yielding a solid fee-related earnings stream. On the investment side, Eurazeo’s portfolio delivers mixed results: core mid-market companies grow earnings nicely (perhaps high single-digit annual EBITDA growth), but occasional setbacks or slower IPO markets keep overall NAV growth modest. The firm continues to rotate ~15–20% of the portfolio each year, achieving some exits at decent multiples (especially for its top performers) but also holding some investments longer due to lukewarm market conditions. We assume NAV per share in 5 years is roughly flat to slightly higher than today – say around €110 (after paying out dividends, which essentially transfer a portion of NAV to shareholders annually). In terms of market valuation, the discount to NAV persists but improves a bit as the company proves resilient: perhaps the stock trades at ~0.7x NAV in 2030 (investors still apply a conglomerate discount, but recognize the stable fee income). Outcome: With ~€110 NAV/share and a 0.7x multiple, the share price could be ~€77 in five years. Adding dividends, the total return would be decent (on the order of 50% cumulatively, or ~8–9% annualized). A possible price trajectory: <table> <tr><th>Year</th><th>Base-Case Share Price (€)</th></tr> <tr><td>2025 (current)</td><td>52</td></tr> <tr><td>2026</td><td>56</td></tr> <tr><td>2027</td><td>60</td></tr> <tr><td>2028</td><td>66</td></tr> <tr><td>2029</td><td>72</td></tr> <tr><td>2030</td><td>~77</td></tr> </table>
This reflects a gradual, modest uptrend as Eurazeo steadily grows and the market warms slightly to the story. Probability: This Base case is our most likely scenario, assigned 50% probability, given current information and a balanced outlook.
Low Case (pessimistic fundamentals): Key drivers: The Low case envisions a difficult environment for Eurazeo. Perhaps macroeconomic conditions deteriorate (a recession or an era of higher-for-longer interest rates), causing private markets to stagnate. AUM growth slows to a crawl – Eurazeo raises only small follow-on funds, with maybe 0–2% net AUM growth per year (essentially new money just offsets distributions). Fee revenue thus plateaus, and any expansion in margins is limited by cost inflation or the need to support new strategies. On the investment side, the portfolio underperforms: some companies struggle or fail in a tough economy, forcing Eurazeo to mark down values. The exit market is weak, so realizations are sporadic and often at lower multiples than hoped. In this scenario, NAV per share erodes over time – for instance, starting at ~€103 and potentially dipping to ~€90 in five years, either due to write-downs or because the company pays out more in dividends/share buybacks than it replenishes via value creation. Market sentiment would likely remain bearish, possibly even assigning a deeper discount to NAV if confidence in private assets wanes further. We assume the stock might trade at only ~0.5x NAV (similar to or worse than today’s discount) by 2030, reflecting persistent skepticism. Outcome: With ~€90 NAV/share and a 0.5x multiple, the share price might be around €45 in five years. Even factoring in dividends collected over time, the total return would be roughly flat to slightly negative. A notional share price path could be: <table> <tr><th>Year</th><th>Low-Case Share Price (€)</th></tr> <tr><td>2025 (current)</td><td>52</td></tr> <tr><td>2026</td><td>50</td></tr> <tr><td>2027</td><td>47</td></tr> <tr><td>2028</td><td>45</td></tr> <tr><td>2029</td><td>44</td></tr> <tr><td>2030</td><td>~45</td></tr> </table>
Here, the share finds a floor in the mid-40s, but doesn’t appreciably rise, as fundamentals disappoint. Notably, even in this downbeat scenario, investors might roughly break even in total return when including the ~5% annual dividend yield (i.e. dividends could compensate for a mild share price decline over five years). Probability: We assign the Low case a 25% probability. While certainly possible, it would likely require a confluence of negative factors (severe recession, very weak markets) to materialize in this way.
Finally, by applying our probability weights to each scenario’s outcome, we can estimate a probability-weighted price target for five years out. Using our figures: High (€114 * 25%) + Base (€77 * 50%) + Low (€45 * 25%) = ≈€78. This suggests a potential €75–80 share price in five years on a risk-adjusted basis – substantially higher than today’s price, though of course the actual outcome will vary. Overall, the balance of scenarios skews to the upside in our view, given the current deep discount and the company’s solid positioning. Catchy Summary: Asymmetric Upside
Management Alignment – 7/10: Eurazeo’s management and governance seem reasonably aligned with shareholder interests. Top executives and board members (including representatives of long-term family shareholders) hold stakes in the company, though the co-CEOs themselves are relatively new in their roles (appointed in 2022) and not founders. The firm’s decision to double its share buyback program to €400 million in 2025 indicates that management is attuned to the undervaluation of the shares and is taking action to return capital. While there is always room for stronger insider ownership, the presence of influential shareholders on the board (e.g. the Decaux family) and performance-based compensation for executives provide a solid alignment framework.
Revenue Quality – 7/10: Eurazeo’s revenue mix is improving in quality but still has a volatile component. On one hand, about two-thirds of its AUM is third-party money, generating recurring management fees that are relatively stable and predictable year to year. The firm’s Fee-Paying AUM rose +8% in 2024, which supports a growing base of high-quality, annuity-like fee income. On the other hand, a significant portion of Eurazeo’s earnings is tied to investment gains and carried interest, which are inherently cyclical. The 2023–2024 swing from a huge net gain to a net loss underscores that portion’s volatility. The trend is positive (fees are becoming a larger share of total EBITDA), but the overall revenue quality is mixed at present – hence a middle-of-the-road score.
Market Position – 8/10: Eurazeo holds a strong market position, particularly in the European mid-market private equity and private debt space. It is recognized as a leading European private asset manager with a diversified platform. The firm competes with both larger global players and specialized local funds, but Eurazeo has carved out a niche through its multi-strategy approach and ability to build “European champions” in the mid-market. Fundraising results have been solid (e.g. one of the largest growth funds in Europe raised in 2025 at €650m), suggesting Eurazeo is winning mandates even in a tougher environment. That said, competition in private markets is intense (peers like Ardian, CVC, etc., vie for deals and investor capital), so Eurazeo must continuously perform to maintain its edge. Overall, its brand, scale, and track record give it an enviable market position in its chosen segments.
Growth Outlook – 7/10: The growth outlook for Eurazeo is moderately positive. The company’s own guidance and strategy imply mid-to-high single-digit AUM growth in coming years, and 2024’s 23% jump in fundraising shows there is demand for its offerings. Secular trends – such as more institutions allocating to private debt/infrastructure and retail investors seeking alternatives – support growth. Eurazeo is also expanding geographically and launching new funds, which could open up incremental growth. However, macro headwinds (higher rates, economic uncertainty) could cap growth in the near term, as evidenced by flat H1 2025 fundraising vs H1 2024. We expect growth to continue, but not explosively – hence a score of 7 reflecting good but not guaranteed growth prospects.
Financial Health – 7/10: Eurazeo’s financial health is sound. The company has a strong balance sheet with €7.4bn in investment assets vs. €1.5bn in gross debtinvesting.com, and a long history of conservative financing. Its balance sheet gearing (~20% net debt to assets) is quite moderate, and it maintains substantial “dry powder” (cash and undrawn commitments) to support portfolio companies or new deals. Interest coverage appears weak on an accounting basis due to recent losses, but importantly Eurazeo’s free cash flow from management fees remains positive and covers operating costs. The firm also has flexibility to raise cash by partial exits or bringing in co-investors if needed. The score is not higher mainly because any investment company is somewhat exposed to market conditions – a severe crisis could stress liquidity – but overall Eurazeo is in solid financial shape with prudent leverage.
Business Viability – 8/10: Eurazeo’s business model is robust and likely to remain viable over the long term. The alternative assets industry has high barriers to entry (track record, investor relationships, regulatory compliance), and Eurazeo has been in operation for decades, building a durable franchise. The diversity of its strategies (PE, debt, real assets) means it can adapt to investor preferences (for example, if private equity is out of favor, private credit might be in favor, etc.). With permanent capital on its balance sheet and a move toward more annuity-like fee income, Eurazeo is less vulnerable to a single shock. Additionally, Eurazeo’s commitment to ESG and impact investing (15% of AUM dedicated to impact funds) positions it well as sustainability becomes a key focus. We see very low risk that Eurazeo’s business will “go away” – it scores 8, reflecting a resilient model, only shy of the top marks because no business is completely immune to external shocks.
Capital Allocation – 8/10: In recent years, Eurazeo’s capital allocation has been shareholder-friendly and strategic. The firm has consistently paid an increasing dividend (2025 dividend +10% to €2.65) and used excess cash to repurchase shares when they trade at a deep discount (a smart accretive move). Internally, management has shown discipline in recycling capital – selling assets when value is realized (e.g., the exits of Albingia, Iberchem, etc.) and not hesitating to write down underperformers to redeploy capital more productively. The fact that Eurazeo doubled its buyback budget in the face of a low share price is a positive signal. The company also balances growth and returns: it continues to invest in new funds and acquisitions (like the stake in IM Global Partner and Trinity Street AM to expand distribution), aiming to boost future earnings. We award 8/10 because capital is being allocated in ways that enhance long-term shareholder value. The only critique preventing a higher score might be the legacy investments that incurred write-offs – one could argue those funds could have been better allocated initially – but the response to cut losses and refocus is underway.
Analyst Sentiment – 9/10: External sentiment from analysts is strongly positive. The majority of covering analysts currently rate Eurazeo a “Buy” or equivalent, with price targets well above the current price (many in the €80–100+ range). For instance, Kepler Cheuvreux and AlphaValue both have targets around €100 (Buy), and Goldman Sachs at €81 (Buy), reflecting a view that the stock is undervalued. Even more conservative voices (Autonomous with Neutral/€70, or Degroof with Reduce/€65) have target prices around or above the current market price. This bullish consensus suggests that knowledgeable market observers see significant upside. The score is 9 because such unanimous positivity is relatively rare – it indicates a strong belief that the company is on the right track or mispriced. We stop short of 10 (perfect sentiment) simply because the stock is still lagging (meaning the positive view hasn’t fully translated into market action yet), but it’s clear analysts are, on average, optimistic about Eurazeo.
Profitability – 6/10: This score balances Eurazeo’s potential profitability with its recent profitability. As an asset manager, Eurazeo’s fee business has attractive economics: ~35% FRE margin and growing, which is good. However, on a consolidated basis, profitability has been inconsistent due to the investment side. The firm had net losses in 2022 (underlying) and 2024, and only a big accounting gain made 2023’s result positive. That volatility drags down the average return on equity. Over a full cycle, Eurazeo does generate solid profits (realized gains tend to come in waves), but it’s not as steady as a traditional corporation. We expect profitability to improve as more fee revenue and carry from exits flow in over the next few years, but for now a 6/10 reflects that current earnings are below their potential. The dividend is well-covered by accumulated gains and cash, but improving recurring earnings will be key to boosting this score.
Track Record – 7/10: Eurazeo has a generally positive track record in terms of long-term value creation, but with some caveats. On one hand, the company has multiplied in size over the past decade (AUM up, global expansion, several investment successes). Their funds have achieved around 12% average returns historically, which is respectable and suggests that they have created wealth for fund investors. Shareholders have also benefited from regular dividends and periodic stock price increases (for example, Eurazeo’s stock has outperformed many European financial indices over multi-year spans when including dividends). On the other hand, the stock’s performance has been choppy, and it currently trades roughly at the same level it did several years ago, implying limited capital appreciation for long-term holders unless dividends are included. Part of this is due to the listed-private-equity discount phenomenon, but part is due to some investments not panning out (the “legacy assets” impairments in 2024 hint at past mistakes that eroded value). The blended score of 7/10 recognizes that Eurazeo has a decent record of growth and value creation, but not without setbacks. It has created shareholder value, just not in a smooth or very high-magnitude fashion.
Overall Blended Score: ~7.5/10. Averaging the above factors, Eurazeo scores around the mid-to-high 7s on a ten-point scale. This suggests a company with solid overall quality – strong in areas like market position, alignment, and capital management, while only average in current profitability and with some risk overhangs. The scorecard paints Eurazeo as a fundamentally robust platform with a few cyclical challenges. Catchy Summary: Solid Platform
Eurazeo SE presents an interesting case of a high-quality investment business trading at a substantial discount. The company has built a diversified private markets platform that is delivering growth in fee income and demonstrating resilience in an uncertain environment. Key catalysts going forward include: continued asset monetizations (successful exits from holdings like Albingia, and potential upcoming sales such as the CPK Group stake, will both realize hidden value and generate cash returns), fundraising milestones (launching new flagship funds in Infrastructure or Venture, or attracting sizable commitments from North American or Asian LPs would validate the growth strategy), and capital return actions (the ongoing share buyback and dividend growth directly accrue value to shareholders, especially if the stock remains undervalued). There is also the softer catalyst of market sentiment normalization – as inflation and rate pressures ease over the next few years, investors may rotate back into discounted alternative asset managers, closing the valuation gap.
That said, the risks and uncertainties cannot be ignored. Eurazeo’s earnings will likely remain lumpy and somewhat opaque in the near term, which can be uncomfortable for public market investors. If the macroeconomic backdrop worsens – e.g., a protracted recession – Eurazeo could face a double-whammy of slower fundraising and further portfolio write-downs, which would test its ability to grow and could keep the stock depressed. Moreover, as a European company, Eurazeo’s valuation might stay lower than U.S. peers’ due to structural factors (European markets often assign lower multiples to investment companies, and liquidity for RF.PA stock is not as high as for global peers).
Investment Thesis: For long-term investors, Eurazeo offers a compelling “sum-of-the-parts” value play. You are essentially buying a stake in a well-managed portfolio of private companies plus a growing asset management franchise, at roughly half of book value. The downside appears mitigated by that asset backing and a 5% dividend yield that pays you to wait. The upside could be significant if Eurazeo executes on its plan – even a partial closing of the discount or a return to modest NAV growth could yield strong returns. In our probability-weighted analysis, we see a plausible path to ~€75–80 share price in five years (around 50%+ upside from today), with a range of outcomes around that depending on the cycle. This asymmetry – solid fundamentals and balance sheet, versus a pessimistic market price – forms the crux of the bull case. Still, patience is required; catalysts like major exits or multiple expansion may take a couple of years to materialize, and quarterly earnings will be noisy. Investors should be prepared for volatility. Overall, Eurazeo’s mix of dependable fee income, valuable hard assets, and proactive management make it an attractive long-term investment for those who can tolerate the illiquidity and cyclicality of private markets exposure. Catchy Summary: Cautious Optimism
Eurazeo’s stock has been in a downtrend over the past year. It is currently trading well below its 200-day moving average, reflecting sustained bearish momentum. In late July 2025, the share price plunged ~14% in a single day after the H1 results, from the mid-€60s to mid-€50s, and subsequently drifted to a 52-week low around €50.65 on July 31. At ~€52, the stock is only marginally above that low. This weak price action indicates that, in the short term, market sentiment is quite negative – likely due to the recent net loss and general risk-off attitude toward private equity. Absent a fresh catalyst, the stock may continue to trade sideways or with a downward bias in the near term, as investors look for signs of stabilization (such as an uptick in exits or a broader market rally). However, the oversold conditions could also mean any positive news (e.g., a lucrative asset sale or a rebound in equity markets) might trigger a relief bounce. In summary, the short-term outlook is cautious: the stock is under technical pressure and needs a catalyst to reverse its slide. Catchy Summary: Under Pressure
View Eurazeo SE (RF.PA) stock page
Loading the interactive version of this report…